Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
about
Non-coding variants contribute to the clinical heterogeneity of TTR amyloidosis.Current and future treatment of amyloid diseases.Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI
P2860
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@ast
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@en
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@nl
type
label
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@ast
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@en
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@nl
prefLabel
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@ast
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@en
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@nl
P2093
P2860
P1433
P1476
Oculoleptomeningeal Amyloidosi ...... eu12Pro in an African patient.
@en
P2093
C J Whelan
D J Werring
D Rowczenio
J A Gilbertson
J D Gillmore
J L Holton
J M Schott
P2860
P2888
P304
P356
10.1007/S00415-014-7594-2
P577
2014-12-09T00:00:00Z
P5875
P6179
1019738327